Evan David Seigerman, BMO managing director, joins ‘Fast Money’ to discuss Novo sinking on its obesity drug data. Source link
Trending
- Wall Street likes these bonds for strong 2025 income
- Amazon workers, port strikes, and an unpredictable 2025 for shippers
- The tricky game of evaluating QBs out of the transfer portal: ‘So many things you don’t know’
- Why the ‘great resignation’ became the ‘great stay’: labor economists
- The ‘weight-loss trade’ has stalled. What it will take to revive interest
- Health care looks cheap going into 2025. How to play it with options
- Two years later, a former Jets play-caller gets the last laugh
- Stocks making the biggest moves midday: Nordstrom, Honda, MicroStrategy, Broadcom and more
Money
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailJared Holz, Mizuho…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneyAndy Constan,…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneyCNBC’s Mike…
The ‘Fast Money’ traders discuss what levels to watch in yields and stocks and their…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email”Fast Money” is…
The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.…
